Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105051 | 12610505 | 1 | I | 20160722 | 20160801 | 20160801 | PER | US-ELI_LILLY_AND_COMPANY-US201607010223 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160801 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105051 | 12610505 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | U | C387371C | 21427 | 20 | MG | CAPSULE | QD | ||||
| 126105051 | 12610505 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | U | 21427 | 20 | MG | CAPSULE | QD | |||||
| 126105051 | 12610505 | 3 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | Y | 0 | CAPSULE | ||||||||
| 126105051 | 12610505 | 4 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Y | 0 | CAPSULE | ||||||||||
| 126105051 | 12610505 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126105051 | 12610505 | 1 | Abdominal pain |
| 126105051 | 12610505 | 2 | Nausea |
| 126105051 | 12610505 | 3 | Abdominal pain |
| 126105051 | 12610505 | 4 | Nausea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126105051 | 12610505 | Abdominal distension | |
| 126105051 | 12610505 | Abdominal pain | |
| 126105051 | 12610505 | Chills | |
| 126105051 | 12610505 | Constipation | |
| 126105051 | 12610505 | Counterfeit drug administered | |
| 126105051 | 12610505 | Decreased appetite | |
| 126105051 | 12610505 | Depressed mood | |
| 126105051 | 12610505 | Disturbance in attention | |
| 126105051 | 12610505 | Fatigue | |
| 126105051 | 12610505 | Feeling hot | |
| 126105051 | 12610505 | Flatulence | |
| 126105051 | 12610505 | Off label use | |
| 126105051 | 12610505 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126105051 | 12610505 | 1 | 2014 | 0 | ||
| 126105051 | 12610505 | 2 | 2014 | 0 | ||
| 126105051 | 12610505 | 3 | 2014 | 2014 | 0 |